Philippe Dauphin-Ducharme, Essam M. Dief, Naïla Corcoran, J. Justin Gooding
4 min
Electrochemical aptamer-based (E-AB) biosensors function by transducing the binding of a target molecule into a measurable change in the electron transfer rate of a redox reporter. While these sensors are prized for their speed, reagentless operation, and ability to function in complex matrices, their performance is not universal. The sensitivity and reliability of the signal depend heavily on the electroanalytical technique used to interrogate the sensor interface.
Analogous to shutter speed in photography, the timescale of an electrochemical measurement—determined by scan rates or pulse frequencies—dictates which interfacial processes are resolved. Because E-AB sensors are dynamic systems with multiple conformational states, the electron transfer rate of the redox reporter is not a single value but an ensemble average. If the measurement timescale is not properly matched to the reporter's electron transfer rate, the sensor may fail to distinguish the target-induced signal from background noise, such as electrical double-layer charging or oxygen reduction.
To translate E-AB sensors into robust, real-world diagnostic tools, researchers must move beyond treating these interfaces as simple two-state systems. Future efforts should focus on refining interrogation methods to account for the multi-state nature of aptamer binding and developing standardized protocols for determining 'true' sensor affinity across varying experimental conditions.
High Resolution Image Download MS PowerPoint Slide Electrochemical aptamer-based biosensors rely on a change in electron transfer to transduce aptamer–target binding into a measurable signal. Depending on the chosen electroanalytical technique, the sensitivity of the method to changes in electron transfer differs and ultimately yields variations in the analytical performance of the sensor. Herein, we provide an overview of how to use different electroanalytical techniques to interrogate electrochemical aptamer-based biosensors and their abilities to resolve changes in electron transfer. In doing so, we discuss the advantages and limitations of the techniques and give perspectives on what the future holds for the electrochemical characterization of such biosensors to accelerate their translation to solve real-world problems.
Alex: That's a surprisingly elegant fix. Instead of rebuilding the sensor, you just adjust how you listen to it.
Sam: That's the key insight. And it also explains why the same sensor can look like it's performing differently in different labs—if two researchers are using different measurement frequencies, they're effectively taking photos at different shutter speeds. They're not seeing the same thing, even though the sensor is identical.
Alex: Are there other tools the paper discusses for dealing with this kind of noise?
Sam: Yes. They also describe a method called Kinetic Differential Measurement. Instead of using a single frequency, you take readings at multiple frequencies and mathematically subtract the background from the signal in real time. It's a bit like noise-canceling headphones—you're actively identifying the unwanted sound and removing it, so what's left is cleaner.
Alex: That sounds powerful. But does using multiple frequencies introduce its own problems?
Sam: It can. If an instrument only samples a limited range of frequencies, you might only be seeing a narrow slice of what the sensor is actually doing. The paper flags this as a real concern—researchers need to validate their results carefully to make sure they aren't accidentally ignoring parts of the sensor that are functioning correctly. The worry is that you could mistake sensor degradation for a genuine binding event, or vice versa.
Alex: So mapping the sensor's response across a wide range of frequencies helps you tell the difference between "the molecule is here" and "the sensor is just wearing out."
Sam: Exactly. By finding the frequency at which the sensor performs best, you get a much cleaner baseline. And that makes it far easier to distinguish a real detection from background drift over time. This matters a lot for applications like continuous drug monitoring, where the sensor might be sitting in the body for hours or days.
Alex: It really does sound like a constant balancing act—speed versus accuracy, signal versus noise.
Sam: It is. And what the paper ultimately argues is that we've been treating these sensors as static objects when we should be thinking of them as dynamic systems. The chemistry is only half the story. The other half is the timing of how you interrogate that chemistry. Get the timing right, and the data becomes significantly more reliable for real-world medical use.
Alex: That's a useful reframe—not just what the sensor is made of, but how you ask it questions. Thanks for walking us through it, and thanks to everyone listening to ResearchPod.